Bergmann Anthony

Capricor Therapeutics, Inc. · CHIEF FINANCIAL OFFICER

Bergmann Anthony is listed in filings as CHIEF FINANCIAL OFFICER at Capricor Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 19, 2026, including sale activity. Recent filings connect the profile to Capricor Therapeutics, Inc. (CAPR). The current snapshot covers public activity from Jan 6, 2025 to May 19, 2026. Reported amounts are shown as $4.2K to $79.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Latest Trades

CompanyValueActionPriceLast Price
Capricor Therapeutics, Inc.CAPR$793k25k sharesSellMay 1, 2026$31.70$19.12